• Home
  • Services
    • Structuring Advice
    • Expansion Capital
    • Business Expansion
    • Exit Mandate
  • Clients
  • Model Options
    • Disruptive Technology Model
    • Environmental Solution Model
    • Value Creation – Sales Magic
    • Geographic Expansion
  • Team
    • Our Team
    • Partners
    • Ecosystem
  • Blog
    • Venture Capital
    • Mergers and Acquisitions
  • Contact
    • Office Details
    • Book Mentoring
Spark Ideas. Ignite Growth. Spark Ideas. Ignite Growth.
  • Home
  • Services
    • Structuring Advice
    • Expansion Capital
    • Business Expansion
    • Exit Mandate
  • Clients
  • Model Options
    • Disruptive Technology Model
    • Environmental Solution Model
    • Value Creation – Sales Magic
    • Geographic Expansion
  • Team
    • Our Team
    • Partners
    • Ecosystem
  • Blog
    • Venture Capital
    • Mergers and Acquisitions
  • Contact
    • Office Details
    • Book Mentoring

Metabomed Completes a $12.5 Million Raise in Order to Advance Its Lead Program Into Clinical Studies

Home » Metabomed Completes a $12.5 Million Raise in Order to Advance Its Lead Program Into Clinical Studies
By Red Pepper Mergers Webmaster
 Posted December 19, 2019
 In Venture Capital
0

VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.

CONTACT US
Blog Topics
  • Venture Capital
  • Mergers and Acquisitions
Recent Posts
  • Do You Have News to Share? Get It Published.
  • After Roaring In 2020, Biotech Stocks Now Weighed Down By Merger Scrutiny, FDA Approval Delays And Possible Drug Pricing Legislation
  • The Radicati Group Releases “Microsoft Office 365, Exchange Server and Outlook Market Analysis, 2021-2025”
  • Merger laws up for reform as regulators team up to tame tech giants
  • Immuno-Oncology Drugs Industry Trends Involve Collaborations, Mergers, Acquisitions Among Market Players
Copyright Red Pepper Mergers. All Rights Reserved ©
  • Sitemap